{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:55:18Z","timestamp":1765886118335,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009443","name":"Universit\u00e9 du Qu\u00e9bec \u00e0 Rimouski","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"FRQS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005969","name":"University of Bologna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.sapharm.2018.09.008","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T01:27:17Z","timestamp":1537406837000},"page":"761-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey"],"prefix":"10.1016","volume":"15","author":[{"given":"Caroline","family":"Sirois","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4344-0359","authenticated-orcid":false,"given":"Marie-Laure","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Maheux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anissa","family":"Frini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.sapharm.2018.09.008_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","article-title":"Aging with multimorbidity: a systematic review of the literature","volume":"10","author":"Marengoni","year":"2011","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.sapharm.2018.09.008_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejim.2012.11.003","article-title":"Patterns of comorbidity and multimorbidity in the oldest old: the Octabaix study","volume":"24","author":"Formiga","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.sapharm.2018.09.008_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/epirev\/mxs009","article-title":"Multimorbidity in older adults","volume":"35","author":"Salive","year":"2013","journal-title":"Epidemiol Rev"},{"year":"2010","series-title":"The Chief Public Health Officer's Report on the State of Public Health in Canada 2010: Growing Older - Adding Life to Years","author":"Public Health Agency of Canada","key":"10.1016\/j.sapharm.2018.09.008_bib4"},{"year":"2016","series-title":"Le bilan d\u00e9mographique du Qu\u00e9bec. \u00c9dition 2016","author":"Institut de la statistique du Qu\u00e9bec","key":"10.1016\/j.sapharm.2018.09.008_bib5"},{"issue":"6","key":"10.1016\/j.sapharm.2018.09.008_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","article-title":"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance","volume":"294","author":"Boyd","year":"2005","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.sapharm.2018.09.008_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"Suppl 1","key":"10.1016\/j.sapharm.2018.09.008_bib8","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.jcjd.2013.01.021","article-title":"Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: pharmacologic management of type 2 diabetes","volume":"37","author":"Harper","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.sapharm.2018.09.008_bib9","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jcjd.2013.01.036","article-title":"Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: treatment of diabetes in people with heart failure","volume":"37","author":"Howlett","year":"2013","journal-title":"Can J Diabetes"},{"issue":"11","key":"10.1016\/j.sapharm.2018.09.008_bib10","first-page":"1342","article-title":"Comprehensive update of the canadian cardiovascular society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"issue":"8","key":"10.1016\/j.sapharm.2018.09.008_bib11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","article-title":"ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the american College of cardiology\/american heart association task force on clinical practice guidelines and the heart failure society of America","volume":"23","author":"Yancy","year":"2017","journal-title":"J Card Fail"},{"issue":"16","key":"10.1016\/j.sapharm.2018.09.008_bib12","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the american College of cardiology foundation\/american heart association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.sapharm.2018.09.008_bib13","first-page":"222","article-title":"CTS position statement: pharmacotherapy in patients with COPD \u2013 an update","volume":"1","author":"Bourbeau","year":"2017","journal-title":"Can J Resp Crit Care Sleep Med"},{"issue":"3","key":"10.1016\/j.sapharm.2018.09.008_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.arbres.2017.02.001","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive Lung disease 2017 report: GOLD executive summary","volume":"53","author":"Vogelmeier","year":"2017","journal-title":"Arch Bronconeumol"},{"issue":"1","key":"10.1016\/j.sapharm.2018.09.008_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ageing\/afs100","article-title":"Guidelines for people not for diabetes: the challenges of applying UK clinical guidelines to people with multimorbidity","volume":"42","author":"Hughes","year":"2013","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.sapharm.2018.09.008_bib16","doi-asserted-by":"crossref","first-page":"e010119","DOI":"10.1136\/bmjopen-2015-010119","article-title":"Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysis","volume":"6","author":"Buffel du Vaure","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2018.09.008_bib17","doi-asserted-by":"crossref","first-page":"h949","DOI":"10.1136\/bmj.h949","article-title":"Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines","volume":"350","author":"Dumbreck","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.sapharm.2018.09.008_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.sapharm.2015.08.011","article-title":"Deprescribing in frail oder people \u2013 do doctors and pharmacists agree?","volume":"12","author":"Page","year":"2016","journal-title":"Res Soc Adm Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2018.09.008_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jacc.2008.10.036","article-title":"The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point","volume":"53","author":"Messerli","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.sapharm.2018.09.008_bib20","first-page":"330","article-title":"Entresto (Sacubitril\/Valsartan): first-in-class angiotensin receptor neprilysin inhibitor FDA approved for patients with heart failure","volume":"8","author":"Fala","year":"2015","journal-title":"Am Health Drug Benefits"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174111830072X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174111830072X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:16:17Z","timestamp":1761556577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155174111830072X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S155174111830072X"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2018.09.008","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2018.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}